KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Liabilities: 2017-2025

Historic Other Non-Current Liabilities for Neogenomics (NEO) over the last 7 years, with Sep 2025 value amounting to $12.0 million.

  • Neogenomics' Other Non-Current Liabilities rose 3.29% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 3.29%. This contributed to the annual value of $11.8 million for FY2024, which is 9.68% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Other Non-Current Liabilities is $12.0 million, which was down 1.04% from $12.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Other Non-Current Liabilities ranged from a high of $14.4 million in Q3 2021 and a low of $3.7 million during Q1 2021.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $12.1 million (2025), whereas its average is $12.4 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first fell by 12.47% in 2021, then surged by 281.47% in 2022.
  • Quarterly analysis of 5 years shows Neogenomics' Other Non-Current Liabilities stood at $14.0 million in 2021, then dropped by 6.90% to $13.1 million in 2022, then dropped by 0.16% to $13.0 million in 2023, then dropped by 9.68% to $11.8 million in 2024, then rose by 3.29% to $12.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $12.0 million for Q3 2025, versus $12.1 million for Q2 2025 and $11.9 million for Q1 2025.